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Summary
Autoimmunity increases with aging indicative of reduced
immune tolerance, but the mechanisms involved are poorly
defined. In recent years, subsets of B cells with immunoregu-
latory properties have been identified in murine models of
autoimmune disorders, and these cells downregulate immune
responses via secretion of IL10. In humans, immature transi-
tional B cells with a CD19+CD24hiCD38hi phenotype have been
reported to regulate immune responses via IL10 production. We
found the frequency and numbers of CD19+CD24hiCD38hi cells
were reduced in the PBMC pool with age. IL10 expression and
secretion following activation via either CD40, or Toll-like
receptors was also impaired in CD19+CD24hiCD38hi B cells from
healthy older donors. When investigating the mechanisms
involved, we found that CD19+CD24hiCD38hi B-cell function
was compromised by age-related effects on both T cells and B
cells: specifically, CD40 ligand expression was lower in CD4 T
cells from older donors following CD3 stimulation, and signal-
ling through CD40 was impaired in CD19+CD24hiCD38hi B cells
from elders as evidenced by reduced phosphorylation (Y705)
and activation of STAT3. However, there was no age-associated
change in expression of costimulatory molecules CD80 and
CD86 on CD19+CD24hiCD38hi cells, suggesting IL10-dependent
immune suppression is impaired, but contact-dependent sup-
pressive capacity is intact with age. Finally, we found a
negative correlation between CD19+CD24hiCD38hi B-cell IL10
production and autoantibody (Rheumatoid factor) levels in
older adults. We therefore propose that an age-related decline
in CD19+CD24hiCD38hi B cell number and function may contrib-
ute towards the increased autoimmunity and reduced immune
tolerance seen with aging.
Key words: autoimmunity; B cells; cellular immunology;
inflammation; rheumatoid factor.
Introduction
B cells have been shown to play a pathogenic role in human
autoimmune diseases due to their ability to secrete autoantibodies and
serve as antigen-presenting cells to T cells (Yanaba et al., 2008b).
Recently, evidence has emerged for a regulatory role of B cells in limiting
immune responses, analogous to the suppressive activity of regulatory T
cells. Janeway and colleagues suggested that B cells were involved in
suppression of inflammation, reporting that the absence of B cells
exacerbated the course of T-cell-mediated autoimmune reactions (Wolf
et al., 1996). Thus, B cells can play both protective and pathogenic roles
in the same pathological setting. Since then a subset of B cells with
immunosuppressive properties have been isolated and shown to
suppress inflammation in a number of murine models of chronic
inflammation, including collagen-induced arthritis (CIA), experimental
autoimmune encephalitis (EAE) and inflammatory bowel disease (Mauri
& Bosma, 2012). Two phenotypically distinct subsets of B cells:
transitional CD19+CD24hiCD38hi B cells (Blair et al., 2010) and
CD19+CD5+CD1dhi ‘B10’ B cells (Yanaba et al., 2008a) have been
demonstrated to exert immunosuppressive functions. Recently, an
additional B-cell subset of CD24hi CD27+ B cells, with 60% of these
cells expressing CD38, has been identified with characteristics similar to
mouse B10 cells (Iwata et al., 2011).
In humans, CD19+CD24hiCD38hi and CD19+CD5+CD1dhi B cells
mediate their immunosuppressive effects via secretion of the regulatory
cytokine IL10 and/or by contact-dependent interaction with pathogenic
T cells (Mizoguchi & Bhan, 2006). IL10 plays an essential role in
maintaining immune homoeostasis. Its biological functions include
downregulation of antigen presentation by macrophages and DCs and
suppressing production of pro-inflammatory cytokines by CD4 T cells,
monocytes and macrophages (Moore et al., 2001). IL10-producing
CD19+CD24hiCD38hi B cells are also able to promote expansion of IL10-
producing Foxp3+ regulatory T cells and have been reported to play a
role in inducing recruitment of Treg cells to the site of inflammation
(Mann et al., 2007). Human IL10-producing B cells have also been
shown to regulate innate immune responses by reducing TNFa produc-
tion by monocytes (Iwata et al., 2011).
The B7 family of costimulatory molecules B7-1(CD80) and B7-2
(CD86) is capable of regulating T-cell growth, survival and differenti-
ation via ligation to CD28 and cytotoxic T lymphocyte protein 4
(CTLA4) receptor on T cells (Collins et al., 2005). In addition to IL10
production, the suppressive effect of CD19+CD24hiCD38hi B cells is also
mediated via engagement of CD80 and CD86 (Blair et al., 2010; Mauri
& Bosma, 2012). For example, B7 expression by B cells is required for
mediating recovery in murine models of autoimmunity by mediating
peak expression of IL10 and Foxp3 (Salomon & Bluestone, 2001).
Additional IL10-independent protective functions in B-cell subsets
include expression of granzyme B by a subset of CD5+ve B cells,
expression of FasL after activation by mitogens, and a subset of TGF
secreting B cells have also been identified (Klinker & Lundy, 2012).
Interestingly, Salmonella infection also results in rapid differentiation of
IL10 expressing plasma-cell-like B cells (CD19+ CD138+), involving TLR
signalling (Neves et al., 2010).
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In this study, we have focussed upon the CD19+CD24hiCD38hi and
CD19+CD5+CD1dhi B cells due to their established role in autoimmune
pathogenesis in rodent models and their reduced activity in autoimmune
disease in humans (Blair et al., 2010; Iwata et al., 2011). Development,
maturation and expansion of B cells with immunosuppressive properties
require specific external signals (Mauri & Bosma, 2012). CD40 engage-
ment plays a pivotal role in their generation and function, halting B-cell
differentiation into plasma cells and facilitating differentiation into cells
with regulatory properties (Randall et al., 1998). In addition to T-cell-
dependent stimulation, B cells can also be activated by microbial
products via Toll-like receptor (TLR) signalling (Yanaba et al., 2009).
Expression of TLR1, TLR2, TLR4, TLR7 and TLR9 transcripts has been
reported on B cells (Barr et al., 2007), and TLR-activated B cells are
capable of resolving autoimmune disorders by inhibiting pathogenic T
cells via IL10 production (Lampropoulou et al., 2008).
The incidence of autoimmune conditions such as rheumatoid arthritis
(RA) increases with age and is also characterized by pathological features
typical of age-related immune dysfunction, termed immunesenescence
(Lindstrom & Robinson, 2010). This raises the possibility that immunese-
nescence may be a contributing factor in the development of autoim-
munity. Age-related T-cell senescence has been associated with
autoimmunity, and an inverse relationship has been reported between
thymic capacity and the incidence of RA (Weyand et al., 2003). Naturally
occurring CD4+CD25+Foxp3+ regulatory T cells play an essential role in
regulating immune responses and preventing autoimmunity. Although
older adults are characterized by higher numbers of Tregs, a decline in the
per cell immune suppressive activity of these cells has been reported
(Dejaco et al., 2006). Reduced immune tolerance with age is also
supported by reports of higher autoantibody levels such as rheumatoid
factor, in healthy older adults (Moulias et al., 1984). It has also been
hypothesized that self-reactive memory B cells accumulated with age
may become reactivated later in life due to deficiency in immune
tolerance leading to elevated autoantibody levels in the elderly (Stacy
et al., 2002). Thus, the current literature suggests the increased
incidence of autoimmune disorders with age may result from a reduction
in immune regulatory function.
In this study, we describe for the first time a decline in the number
and immunoregulatory function of IL10-producing B cells with age,
which is negatively correlated with the age-related increase in the
circulating autoantibody rheumatoid factor, providing an important
additional mechanism for the age-related increase in autoimmunity.
Results
Effect of age on the frequency of circulating
CD19+CD24hiCD38hi B cells
Three major populations of circulating B cells have been reported in
peripheral blood: transitional, circulating mature na€ıve and memory B
cells discriminated on the basis of relative distribution of the markers
CD24 and CD38. Functionally, immature transitional CD19
+CD24hiCD38hi B cells have been reported to comprise the highest
percentage of IL10-producing B cells upon CD40 stimulation (Blair et al.,
2010). Peripheral blood mononuclear cells (PBMC) isolated from young
and older subjects were stimulated for 72 h with anti-CD3 antibody prior
to immunostaining for the expression of CD19, CD24, CD38 and IL10 in
order to identify B cells with regulatory properties (Blair et al., 2010). The
gating strategy used to identify these cells is shown in Fig. 1A. Our
findings are consistent with the previous literature that has reported that
CD19+CD24hiCD38hi cells are the main IL10-producing subset induced in
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Fig. 1 CD19+CD24hiCD38hi B cells are the
main producers of IL10 amongst B cells and
their numbers decline with age. PBMCs
were isolated from peripheral blood,
stimulated using anti-CD3 antibody for
72 h and immunostained for expression of
CD19, CD24, CD38 and intracellularly
stained to measure IL10. (A) Representative
flow cytometric plot showing the gating
strategy used to identify regulatory B cells in
the B-cell pool via expression of CD24 and
CD38, (B) IL10 expression on B-cell subsets
following T-cell-dependent stimulation via
CD3 (upper panel) or T-cell independent
stimulation via LPS (lower panel). (C) Scatter
plot showing the percentages
CD19+CD24hiCD38hi B cells in peripheral
blood of 35 healthy young donors and 35
healthy old donors without stimulation. The
solid bar represents the mean value. (D) Bar
chart showing the mean absolute number
of CD19+CD24hiCD38hi B cells in peripheral
blood of healthy young and old donors.
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a T-cell-dependent manner, (Fig. 1B, upper panel) compared with
CD24+veCD38veB (memory) and CD24+veCD38ve (mature) B cells that
produce little or no IL10 (Fig. S1 A). Similarly, we have also confirmed
that CD19+CD24hiCD38hi cells are the main IL10 producers in the
B-cell pool upon LPS stimulation (Fig. 1B, lower panel), whereas
CD24+veCD38veB (memory) and CD24+veCD38+ve (mature) B cells
produced very low levels of IL10 on LPS stimulation (Fig. S1 B). Tedder
and colleagues have also reported that IL10 production was restricted to
CD5+CD1dhi B cells and referred to them as ‘B10’ cells showing that this
subset expressed high levels of CD24 in mice (Yanaba et al., 2008a).
IL10-producing B cells in humans are also CD5+CD1dhiCD24hiCD38hi
CD27+ (Iwata et al., 2011), but Mauri and colleagues have shown that
the IgD+ve CD27ve CD5+CD1dhi B-cell subset was contained within the
CD19+CD24hiCD38hi population in humans (Blair et al., 2010). Despite
this observation, we routinely assessed the CD19+CD5+CD1dhi popula-
tion of cells in our study and confirmed their presence in humans and
that they responded to T-cell-mediated and TLR signalling by induction
of IL10 (data not shown). As we found that the two populations
behaved identically in each experiment, only the data for the
CD19+CD24hiCD38hi cells are presented.
Comparison of these subsets in healthy young and old subjects
revealed that the percentage of both the CD19+CD24hiCD38hi (Fig. 1C)
and CD19+CD5+CD1dhi B cells (Fig. S2 A) in the PBMC pool was
significantly reduced in older adults. We also evaluated whether there
was a numerical deficit in CD19+CD24hiCD38hi and CD19+CD5+CD1dhi
B cells in old donors and found a significant reduction in absolute
numbers of CD19+CD24hiCD38hi B cells (Fig. 1D) and
CD19+CD5+CD1dhi B cells (Fig. S2 B) coinciding with the well-
documented decrease in total B cell numbers with age (Cancro et al.,
2009).
Impaired IL10 production by B cells with age
The hallmark of the immunosuppressive function of B cells is their ability
to produce IL10 (Blair et al., 2009). To examine the effect of aging on
immunosuppressive properties of B cells, we first determined the per-
centage of IL10 expressing CD19+CD24hiCD38hi and CD19+CD5+CD1dhi
B cells following stimulation of T cells in the PBMC pool with anti-CD3
mAb for 72 h. We observed a significant decline in the percentage of
IL10 expressing CD19+CD24hiCD38hi (Fig. 2A) and CD19+CD5+CD1dhi B
cells (data not shown) in older individuals. We also compared the level of
IL10 expressed by the individual CD19+CD24hiCD38hi B cells, but did not
observe any significant differences in the mean fluorescence intensity
(MFI) values after immunostaining for IL10 expression by
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Fig. 2 Impaired IL10 production by
CD19+CD24hiCD38hi B cells on CD3
stimulation with age is due to impaired
T-cell helper activity. PBMCs isolated from
15 healthy young and older adults were
stimulated via CD3 for 72 h and stained for
surface expression of CD19, CD24, CD38
and intracellularly for IL10. (A) Scatter plots
show the percentage of IL10 positive cells
within the CD19+CD24hiCD38hi B-cell
subset in healthy young and old donors;
(B) Bar charts showing the mean
fluorescence intensity of IL10 staining
within CD19+CD24hiCD38hi B cells after
72 h; (C) PBMCs isolated from 30 healthy
young and older adults were stained for
CD19, CD24, CD38 and CD40. Scatter plot
shows the percentage of
CD40+veCD24hiCD38hi B cells in
unstimulated peripheral blood of healthy
young and aged donors; (D). Bar chart
comparing the expression of CD40 (MFI) on
CD19+CD24hiCD38hi B cells without
stimulation between young and old donors;
(E) Representative flow cytometric plots
showing the percentage of CD40L+ CD4T
cells in healthy young and old donors after
CD3 stimulation for 72 h; (F) Scatter plots
showing the mean percentage of CD40L+
CD4T cells in PBMCs of 15 healthy young
and older donors.
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CD19+CD24hiCD38hi cells (Fig. 2B). Previous studies in human
CD19+CD24hiCD38hi B cells have routinely included 6-h stimulation
with PMA and ionomycin at the end of the 72-h anti-CD3 treatment
(Blair et al., 2010). However, the inclusion of PMA and ionomycin
treatment did not rescue the impaired induction of IL10 expressing
CD19+CD24hiCD38hi B cells in PBMC from old donors (data not shown).
The effect of age is thus at the stage of induction of immature
transitional CD19+CD24hiCD38hi and CD19+CD5+CD1dhi B10 B -cell
differentiation into IL10-producing cells.
Decline in CD4 T-cell helper activity with age
T cells activated through the TCR/CD3 pathway provide a costimulatory
signal for inducing IL10 secretion by CD19+CD24hiCD38hi B cells via
upregulation of CD40 ligand (CD154). To investigate the possible cause
of impaired IL10 production with aging, we examined the stability of
CD40 expression on CD19+CD24hiCD38hi B cells and CD40L expression
on CD4 T cells with age. The proportion of CD40 positive B cells and the
CD40 expression levels on the total B-cell pool remained stable with age
(data not shown), as previously reported (Blaeser et al., 2008). Similarly,
the percentage of CD40 expressing CD19+CD24hiCD38hi B cells (Fig. 2C)
and the CD40 expression levels on CD19+CD24hiCD38hi cells (Fig. 2D)
were comparable between young and aged individuals. In contrast,
immunostaining for CD40L revealed a significant age-related decline in
the percentage of basal CD4+ CD40L+ T cells (data not shown) and a
significant reduction in CD3-induced CD40L expression on CD4 T cells in
old donors (Fig. 2E and 2F). Although the level of CD40L induction is
low, these figures are in line with a previous report that recorded 7.8%
of T cells expressing CD40L after 72-h stimulation (Kosmaczewska et al.,
2006). With age, CD4 T cells thus show a decline in their ability to
provide an activating stimulus to B cells, which would contribute to
impaired induction of IL10.
Intrinsic defects in CD19+CD24hiCD38hi B cells of older adults
result in impaired IL10 production
Next, we evaluated whether CD19+CD24hiCD38hi and CD19+
CD5+CD1dhi B cells also exhibit cell-intrinsic defects in response to
CD40 stimulation. Isolated B cells were stimulated for 48 h with
recombinant CD40L, and a significant age-related decline in the
induction of IL10 expression was observed in CD19+CD24hiCD38hi
(Fig. 3A) and CD19+CD5+CD1dhi B cells (data not shown) in older
individuals. Additionally, we also measured IL10 secretion by B cells after
stimulation (48 h) with recombinant CD40L. Assessment of IL10 in
culture supernatants by ELISA showed that IL10 secretion was signifi-
cantly lower by cells from old donors (Fig. 3B). The impaired IL10
production upon direct stimulation with CD40L suggests that intrinsic
defects in CD40 signalling in aged IL10-producing B cells may be a
contributing factor towards impaired induction of immunoregulatory
properties.
CD40 signalling results in the activation of multiple signalling
cascades including signal transducers and activators of transcription
factor 3 (STAT3)(Hanissian & Geha, 1997). CD40-mediated STAT3
activation is known to induce IL10 gene expression. Due to the low
numbers of CD19+CD24hiCD38hi cells in peripheral blood, we
assessed STAT3 phosphorylation at tyrosine residue Y705 on a
single-cell basis using phosphoflow cytometry. The percentage of
CD19+CD24hiCD38hi cells expressing phosphorylated STAT3 was
significantly lower in cells from aged donors poststimulation with
anti-CD40 mAb (Fig. 3C).
Impaired IL10 production by B cells in older adults – T-cell
independent stimulation
Toll-like receptor (TLR)-mediated signals can activate protective B-cell
responses and provide a link between microbial recognition and
suppression of autoimmune diseases. We therefore also examined the
effect of TLR4 stimulation via lipopolysaccharide (LPS) for 48 h on
CD19+CD24hiCD38hi and CD19+CD5+CD1dhi B cells in young and older
adults. We saw a significant decline in induction of IL10 expression by
CD19+CD24hiCD38hi (Fig. 3D) and CD19+CD5+CD1dhi B cells (data not
shown) on LPS stimulation in older individuals. We also examined IL10
secretion by B cells and found significantly lower IL10 levels in the culture
supernatant from old donor B cells (Fig. 3E). To investigate the basis of
the impaired IL10 induction on LPS stimulation by CD19+CD24hiCD38hi
B cells, we examined TLR4 expression on B cells from young and old
donors. We observed a significant decline in the percentage of total
TLR4-expressing B cells (data not shown) and specifically in
CD19+CD24hiCD38hi B cells (Fig. 3F) in older adults. However, we did
not detect any significant differences in protein expression on a per cell
basis for TLR4 on CD19+CD24hiCD38hi cells with age (data not shown).
CD80 and CD86 expression on CD19+CD24hiCD38hi
B cells with age
Previous studies have reported that the suppressive activity of B cells is
not exclusively IL10 dependent (Mizoguchi & Bhan, 2006;. Engagement
of CD80/CD86 with CD28 and CTLA4 expressed on T cells has been
proposed as an additional mechanism of suppression by regulatory B
cells (Blair et al., 2010). We found that young and aged donor B cells did
not differ in the percentage of cells expressing costimulatory molecules
CD80 and CD86 (data not shown) or in the levels of expression of
costimulatory molecules (data not shown). Similarly, we found no
differences between the percentage of CD19+CD24hiCD38hi B cells
expressing costimulatory molecules CD80 (Fig. 4A) and CD86 (Fig. 4B)
or in the levels of expression of costimulatory molecules in these cells
(data not shown).
Additionally, we examined the expression of CTLA4 and CD28 on
CD4 T cells with age and observed a significant increase in percentage of
CTLA4 expressing CD4 T cells (Fig. 4C), even though the expression
levels remained unaltered (data not shown). These findings are consis-
tent with previous reports of CTLA4 upregulation with age (Leng et al.,
2002). We also observed a significant decline in the percentage of CD28
expressing CD4 T cells with age (Fig. 4D) that is consistent with previous
findings (Vallejo, 2005). However, we saw no differences in the
expression levels of CD28 on CD4 T cells between young and aged
donors (data not shown).
CD19+CD24hiCD38hi B cells and autoimmunity
The incidence of autoimmunity increases with age (Lindstrom &
Robinson, 2010). For example, approximately 25% of older adults have
detectable levels of low-affinity autoantibodies in their blood, including
rheumatoid factors (RFs), which are present in only 5% of young healthy
individuals (Moulias et al., 1984). Here, we have shown a numerical and
functional impairment in the subset of IL10-producing B cells with age,
and we thus questioned whether this impairment may contribute
towards increased risk of autoimmunity with age. On testing serum RF
levels of healthy young and aged individuals, we observed a significant
increase in serum RF levels in older adults compared with young adults
(Fig. 5A) and a significant negative correlation between RF antibody titre
CD19+CD24hiCD38hi B cells and aging, N. A. Duggal et al.876
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levels and IL10 production by CD19+CD24hiCD38hi B cells (P = 0.015;
Fig. 5B). These results suggest that age -associated impairment in the
ability of CD19+CD24hiCD38hi B cells to produce IL10 with age may be
linked with the elevated risk of autoimmunity with age.
Discussion
Advancing age is associated with remodelling of the immune system that
predisposes elders to the development of autoimmune disorders such as
rheumatoid Arthritis (Lindstrom & Robinson, 2010). These changes
include reduced levels of circulating IL10 with raised levels of pro-
inflammatory cytokines, termed ‘inflammaging’ (Franceschi, 2007) and
Tregs with reduced immune suppression activity in older adults (Dejaco
et al., 2006). Aging is also accompanied by compromised peripheral
tolerance, represented by increased levels of autoantibodies in the
circulation, suggesting a physiological impact of reduced T regulatory
cell function. However, studies over the past decade have challenged the
paradigm of Treg cells as the sole cell type involved in regulation of
immune responses and B cells with immunosuppressive properties have
also been identified in humans (Blair et al., 2010; Iwata et al., 2011).
Furthermore, the ability of B cells to secrete IL10 has been shown to be
impaired in autoimmune diseases, including SLE (Blair et al., 2010) and
multiple sclerosis (Duddy et al., 2007), and treatment of multiple
sclerosis patients with mitoxantrone, an approved chemotherapy for
aggressive MS, results in increased B-cell IL10 production and lower
production of the pro-inflammatory cytokines TNF and lymphotoxin
(Neuhaus et al., 2005).
Here, we report a profound effect of aging on the frequency and
immunosuppressive function of transitional CD19+CD24hiCD38hi and
CD19+CD5+CD1dhi B10 B cells, resulting from both a lack of T cell help
due to reduced upregulation of CD40L upon activation and reduced
signalling through CD40 on the B cell. Previous studies have reported
impairments in CD4+ T-cell helper activity with age, namely a reduction
in CD40L upregulation by CD4 T cells on stimulation in mice (Eaton
et al., 2004) and humans (Fernandez-Gutierrez et al., 1999). Reduced
CD40L expression on CD4 T cells with age has also been associated with
increased levels of dual-specific phosphatase 4 (DUSP4) in CD4 T cells
from old donors (Yu et al., 2012). In addition, impaired coalescence of
lipid rafts in T cells of older adults following stimulation through CD3 has
been reported (Larbi et al., 2004) and might also play a role in reducing T
cell help for IL10-producing B cells. That aging is accompanied by
intrinsic defects in B cells themselves has also been reported in mice.
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Fig. 3 B cells from old donors display
impaired IL10 secretion upon CD40 (T-cell
dependent) and LPS (T-cell independent)
stimulation. B cells isolated from 15 young,
and older adults were stimulated with
recombinant CD40L for 48 h and
immunostained for surface expression of
CD19, CD24, CD38 and intracellularly for
IL10, and IL10 secretion was measured by
ELISA in culture supernatants. (A) Scatter
plot showing the mean percentage of IL10
positive cells within the
CD19+CD24hiCD38hi B-cell subset in young
and old donor; (B) Bar graphs represent the
mean IL10 concentrations ( SEM) in cell
culture supernatants; (C) PBMCs from five
young and old donors were stimulated with
an agonistic anti-CD40 antibody and cells
fixed and stained for phosphorylated STAT3
(pY705) at the time points shown. Data are
the mean  SD for the percentage of
CD19+CD24hiCD38hi B cells expressing
pSTAT3 and * indicates P < 0.05; B cells
isolated from 15 young and older adults
were stimulated with LPS for 48 h and
immunostained for surface expression of
CD19, CD24, CD38 and intracellularly for
IL10, and IL10 secretion was measured by
ELISA in culture supernatants. (D)
Scatter plot showing the mean percentage
of IL10 positive cells within the
CD19+CD24hiCD38hi B-cell subset; (E) Bar
graphs showing the mean IL10
concentration ( SEM) in cell culture
supernatants; (F) PBMCs isolated from 15
young and older adults were stained with
CD19, CD24, CD38 and TLR4. Scatter plot
showing the percentage of
TLR4+veCD19+CD24hiCD38hi B cells in
peripheral blood without stimulation.
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Adoptive transfer studies in severe combined immunodeficient (SCID)
mice revealed that antibodies produced by B cells from young mice,
when paired with T cells from aged donors, had a reduced rate of
somatic mutation and VH gene usage. However, when aged B cells were
transferred with young T cells, somatic mutation still failed to accumu-
late normally (Yang et al., 1996). Another study highlighting intrinsic
defects in B cells with age reported a decrease in transcription factor E47
expression on anti-CD40 stimulation, resulting in decreased class
switching in aged murine B cells (Frasca et al., 2003). Our data show
that age-related intrinsic B-cell defects extend to CD19+CD24hiCD38hi
and CD19+CD5+CD1dhi cells in humans as we have shown impaired IL10
induction by these immunosuppressive B cells upon direct stimulation
with recombinant CD40L and reduced phosphorylation of STAT3. These
data are consistent with a previous report of impaired STAT3 signalling
with age in human lymphocytes (Fulop et al., 2006). Additionally,
CD19+CD24hiCD38hi B cells from SLE patients have been shown to have
impaired IL10 production upon CD40 activation, and this was correlated
with lower levels of STAT3 (Blair et al., 2010).
A link between reduced B-cell immunoregulatory function and age-
related autoimmunity is supported by our data showing a negative
correlation between CD19+CD24hiCD38hi B-cell IL10 production and
serum Rf levels in our subjects. Previous findings have reported an
exacerbated disease phenotype and enhanced mortality in IL10 gene-
deficient lupus-prone MLR mice, and administration of rIL-10 reduced
autoantibody production, highlighting the importance of IL10 in down
modulating autoimmunity (Yin et al., 2002). Others have shown that
mice lacking IL10-producing B cells develop an exacerbated antigen-
induced arthritis, which is also associated with reduced numbers of Tregs
and increased Th1 and Th17 cells (Carter et al., 2011). Additionally, B7
expression by B cells is also required for their regulatory function,
mediating peak expression of IL10 and Foxp3 (Salomon & Bluestone,
2001). However, we did not observe any difference in levels of
costimulatory molecules on CD19+CD24hiCD38hi with age. IL10-
producing B cells also promote induction of regulatory T-cell function
over inflammatory T-cell function. The reduced functioning of
CD19+CD24hiCD38hi and CD19+CD5+CD1dhi B cells seen here might
therefore contribute not only to loss of Treg function with age (Dejaco
et al., 2006), helping to promote autoimmunity, but also to the age-
related increase in systemic inflammation. IL10 modulates the inflam-
matory function of monocytes, and the raised level of basal monocyte
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Fig. 4 Effect of age on CD80 and CD86
expression on CD19+CD24hiCD38hi B cells
and CTLA4 and CD28 expression on CD4 T
cells. PBMCs isolated from 20 young and
older adults were stained with CD19,
CD24, CD38 and CD80 or CD86. Scatter
plots showing the effect of age on the
percentage of (A) CD80+veCD24hiCD38hi B
cells or (B) CD86+veCD24hiCD38hi B cells in
peripheral blood without stimulation;
Scatter plots showing the percentage of (C)
CTLA4+ CD4T cells and (D) CD28+ CD4T
cells in PBMCs of 20 young and older
donors.
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Fig. 5 Autoantibody levels increase with
age and correlate with reduced IL10
production by CD19+CD24hiCD38hi B cells.
(A) Serum levels of rheumatoid factor (RF)
were measured in 10 healthy old and 10
healthy young donors. Data are
mean  SD. (B) Serum RF values were
plotted against ability of
CD19+CD24hiCD38hi B cell to produce IL10
upon CD3 stimulation of PBMCs in young
(open circles) and old (closed circles)
donors.
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cytokine output with age has been reported in both aged mice (Arranz
et al., 2010) and humans (Franceschi, 2007), termed inflammaging.
Reduced regulatory B-cell function could therefore also contribute to this
age-related phenomenon.
The literature also contains reports of age-associated defects in TLR-
induced cytokine production in monocytes, macrophages and dendritic
cells (Panda et al., 2010), including reduced TLR4 expression and
function on macrophages and dendritic cells with age (Renshaw et al.,
2002). We have shown a significant decline in IL10 production by B
cells in old donors upon LPS stimulation and a reduction in TLR4
expression on aged CD19+CD24hiCD38hi and CD19+CD5+CD1dhi B
cells that may contribute to reduced responsiveness to LPS, which is
also seen in monocytes and DCs with age (Qian et al., 2012). TLR-
signalling pathways in IL10-producing B cells were not investigated
here, but may also contribute to altered IL10 secretion upon LPS
stimulation in older adults. MyD88 is required for optimal IL10
production and secretion following LPS stimulation (Yanaba et al.,
2009).
Interestingly, a novel B-cell subset has been characterized recently by
the Marrack group and suggested to play a role in age-related
autoimmunity: the CD11c+ B cell increases in frequency in aged female
mice leading to the name ‘age-associated B cell (ABC)’. These cells are
also detected in young lupus-prone mice and elderly women with
autoimmune disease (Rubtsov et al., 2011). Although we have not
determined the presence of ABCs in our study, it is interesting to
postulate that their age-related increase is accompanied by a decline in
IL10-producing B cells, representing a remodelling of the B-cell pool
towards autoimmune-enhancing cells.
In summary, our findings demonstrate that the frequency of
CD19+CD24hiCD38hi and CD19+CD5+CD1dhi B cells and their ability
to produce IL10 after ex vivo maturation/stimulation declines with age
and that this correlates with an age-related increase in serum
autoantibody (RF) in healthy older adults. Reduced induction of IL10
secretory function was due to both compromised intrinsic B-cell
signalling through CD40 and reduced expression of CD40L on CD4 T
cells.
Experimental procedures
Subjects
In total, 56 young (mean age 26.81, range 20–36 years) and 65 old
(mean age 70.12, range 60–84 years) subjects participated in this
study. A venous blood sample was taken from each subject between
the hours of 09:00–11:00 am after obtaining written informed
consent. At the time of blood sampling, none of the subjects had an
acute infection or were taking any medication known to alter immune
function (such as steroids or statins) and none had any chronic illness.
The study has been approved by the North Staffordshire Research
Ethics Committee.
Human cell isolation and culture
Peripheral blood mononuclear cells (PBMC’s): PBMCs were isolated from
peripheral blood by density centrifugation using Ficoll-PaqueTM PLUS (GE
Healthcare, Uppsala, Sweden). Isolated PBMC’s were resuspended in
RPMI medium containing 2 mM L-glutamine, 100 U ml penicillin, 100 lg
ml streptomycin (Sigma-Aldrich, Dorset, UK) supplemented with 10%
heat-inactivated fetal calf serum (Sera Laboratories International, Sussex,
UK) at a concentration of 1 9 106 ml1 for functional and phenotypic
analysis.
Immunostaining for phenotypic analysis of B cells and T cells
Isolated PBMCs were stained with a combination of fluorochrome-
conjugated antibodies including: CD19-PE (clone׃ HIB19; eBiosciences,
Hatfield, UK), CD24-FITC (clone׃ eBioSN3; eBiosciences), CD38-PEcy7
(clone׃ HIT2; eBiosciences), CD19-FITC (clone׃ H1B19; eBiosciences),
CD5-PEcy7 (clone׃ UCHT2; eBiosciences), CD1d-PE (clone ׃51.1 ; eBio-
sciences), CD40-APC(clone ׃5 C3; eBiosciences), TLR4 (CD284)-APC
(clone׃ HTA125; eBiosciences), CD80-APC (clone ׃2 D10; Bio legend,
London, UK), CD86-APC (clone׃ IT2.2; Bio legend), CD3-FITC (Dako,
clone׃UCHTI), CD4-PE (clone׃ RPA-T4; eBiosciences), CD154-APC (clone׃
24–31 ; eBiosciences), CTLA4- APC (clone׃ L3D10; Bio legend) and CD28-
APC (clone׃ CD28.2; BD Biosciences) Appropriate isotype controls were
used for setting gates. Following incubation, cells were washed and
resuspended in PBS for flow cytometric analysis using a Cyan TM ADP
flow cytometer (Dako). Mean data are expressed as MFI and as a natural
number rather than on the log scale.
B-cell functional assays – CD3 stimulation
Prior to set-up of stimulation, wells of a 96-well microtitre plates with
round bottom wells (Sarstedt Ltd, Leicester, UK) were coated with
anti-CD3 mAb (BD Biosciences) at a concentration of 0.5 lg ml for 1 h
at 37° C. Isolated PBMCs were plated at 25 9 104 cells/well for 72 h
at 37° C in a humidified atmosphere of 5% CO2. Brefeldin A (10lg
ml1; Sigma-Aldrich) with PMA (50 ng ml1; Sigma-Aldrich) and
ionomycin (500 ng ml1; Sigma-Aldrich) were added during the last
6 h of the incubation. Postculture PBMCs were stained with extracellular
surface expression markers CD3-FITC (Dako, clone׃UCHTI), CD4-PE
(clone׃ RPA-T4; eBiosciences) and CD154-APC (clone31–24; eBioscienc-
es) to measure CD40L (CD154) expression on CD3-stimulated CD4 T
cells.
B-cell isolation and stimulation – CD40L and LPS
B cells were isolated from PBMCs by negative selection using MACS
technology (Human B cell isolation kit; Miltenyi Biotech UK, Gladbach,
Germany) following the manufacturer’s instruction. Isolated B cells were
resuspended in complete medium at 1 9 106 ml1. Purity of isolated B
cells was routinely assessed and was ≥ 92%. B cells were stimulated with
either recombinant human CD40L (1 lg ml1; Peprotech, Hull, UK) or
LPS isolated from Escherichia coli serotype 0111:B4 (1 lg ml1; Sigma-
Aldrich) for 48 h. Brefeldin A (10 lg ml1; Sigma-Aldrich) was added
during the last 6 h of the stimulation. At the end of incubation, B cells
were washed with PBS.
Flow cytometric detection of intracellular IL10
After culturing cells with stimulus, they were washed and stained for a
combination of extracellular surface markers to identify IL10-producing
transitional B cells (CD19 PE, CD24 FITC and CD38 PEcy7) and B10 B
cells (CD19 FITC, CD5 PEcy7, CD1d PE). Poststaining cells were fixed
(Reagent A; Fix and Perm kit, Invitrogen Ltd, Paisley, Scotland) and
permeabilized (Reagent B; Fix and Perm kit, Invitrogen). Permeabilized
cells were stained with anti-human Alexa fluor 647 IL10 antibody (clone׃
JES3-9D7) for intracellular staining. Appropriate APC-conjugated isotype
controls were used for gate setting for measuring cytokine expression.
Quantification of IL10 levels in supernatant
Isolated B cells (1 9 106 cells) were stimulated with either recombinant
human CD40L (1 lg ml1; Peprotech, Hull, UK) or LPS isolated from
Escherichia coli serotype 0111:B4 (1 lg ml1; Sigma-Aldrich) for 48 h (as
described above). Poststimulation, the supernatant was collected and
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IL10 levels were quantified using a Human IL-10 ELISA (Abcam, UK) as
per manufacturer’s instructions.
Measuring phosphorylation of STAT3
PBMCs were rested for 1 h in medium after which cells were stimulated
with purified agonistic anti-human CD40 mAb (eBiosciences) at 0.5 lg
106 per cells for up to 30 min in the dark at 4° C. Poststimulation cells
were washed and stained for a combination of extracellular surface
markers to identify transitional B cells (CD19-PE, CD24-FITC and CD38-
PEcy7) and were then fixed immediately to maintain phosphorylation
state by adding 100 ll of 1.6% paraformaldehyde for 30 min at room
temperature in the dark. Postfixation cells were washed and permea-
bilized using methanol and stained with anti-STAT3 (pY705) phospho-
specific antibody (BD Biosciences, Oxford, UK) and appropriate isotype
controls for 30 min in the dark at 4° C. Cells were analysed using three
and four channel flow cytometry on a CyanTM ADP (Dako). Data analysis
was carried out using Summit v4.3x software (Dako).
Statistical analysis
Statistical analysis was performed using GraphPad Prism (Graph Pad, La
Jolia, USA) software. Data distribution was checked for normality using
the Kolmogorov-Smirnov test. For normally distributed data, a Student’s
t-test analysis was performed to assess differences between two
conditions. P-values of < 0.05 were considered significant.
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Fig. S1 PBMCs were isolated from peripheral blood, stimulated using (A) anti-
CD3 antibody or (B) LPS for 72 h and immunostained for expression of CD19,
CD24, CD38 and intracellularly stained to measure IL10.
Fig. S2 PBMCs were isolated from peripheral blood, stimulated using anti-
CD3 antibody for 72 h and immunostained for expression of CD19, CD1d,
CD5 and intracellularly stained to measure IL10.
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